Recent Advances in the Treatment of Advanced NSCLC with ALK Alterations

home / expert-perspective-tumor-board / recent-advances-in-the-treatment-of-advanced-nsclc-with-alk-alterations

Expert panelists provide an overview of ALK+ NSCLC and present patient cases in the context of key clinical trial data to highlight optimal treatment strategies.

Expert on NSCLC

EP. 1: Overview on ALK+ Metastatic Non–Small Cell Lung Cancer

Stephen Liu, MD;Jyoti D. Patel, MD;D. Ross Camidge, MD, PhD;Jillian E. Thompson, NP, Georgetown University Lombardi Comprehensive Cancer Center
March 10th 2023

Expert panelists open their discussion on ALK+ non–small cell lung cancer and reflect on the impact of CNS metastasis in this setting.

Watch

Expert on NSCLC

EP. 2: Case 1: Frontline Treatment of ALK+ NSCLC With Brain Metastases

Stephen Liu, MD;Jyoti D. Patel, MD;D. Ross Camidge, MD, PhD;Jillian E. Thompson, NP, Georgetown University Lombardi Comprehensive Cancer Center
March 10th 2023

Shared insight on a patient case of ALK+ non–small cell lung cancer with CNS metastasis and the role of brain MRIs in clinical practice.

Watch

Expert on NSCLC

EP. 3: Expert Perspectives on Molecular Testing in Non–Small Cell Lung Cancer

Stephen Liu, MD;Jyoti Patel, MD;D. Ross Camidge, MD, PhD;Jillian E. Thompson, NP, Georgetown University Lombardi Comprehensive Cancer Center
March 20th 2023

Comprehensive discussion on molecular testing strategies utilized in non–small cell lung cancer to help inform treatment decisions.

Watch

Expert on lung cancer

EP. 4: NSCLC: Selecting a Frontline ALK-Targeted TKI Therapy

Stephen Liu, MD;D. Ross Camidge, MD, PhD;Jyoti Patel, MD;Jillian E. Thompson, NP, Georgetown University Lombardi Comprehensive Cancer Center
March 20th 2023

A panel of experts considers which factors best inform selection of first-line ALK TKI therapy in patients with non–small cell lung cancer.

Watch